Harrow Health, Inc.
Harrow Health, Inc.（HROW）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · HROW · 截至 2026年6月8日
活动摘要
买入笔数
4
P-Purchase only
卖出笔数
6
近12个月
买卖比
0.67
Buy/Sell (by trades)
整体情绪
Harrow Health, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
HROW 季度内部人买卖趋势
HROW 内幕交易卖出 · HROW 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · HROW CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
HROW 高管卖出股份 · HROW 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 18, 2026 | Graves Adrienne L Director | Purchase | 1,000 | $31K | Form 4 |
| May 18, 2026 | SILVERNAIL LAUREN P Director | Purchase | 1,000 | $31K | Form 4 |
| May 14, 2026 | BAUM MARK L CHIEF EXECUTIVE OFFICER · Director | Purchase | 10,000 | $302K | Form 4 |
| May 14, 2026 | BOLL ANDREW R. PRESIDENT AND CFO | Purchase | 3,500 | $105K | Form 4 |
| Dec 12, 2025 | BOLL ANDREW R. PRESIDENT AND CFO | Option | 60,000 | $237K | Form 4 |
| Dec 12, 2025 | BOLL ANDREW R. PRESIDENT AND CFO | Other | 26,665 | $1.25M⚡ | Form 4 |
| Dec 12, 2025 | BAUM MARK L CHIEF EXECUTIVE OFFICER · Director | Option | 180,000 | $711K | Form 4 |
| Dec 12, 2025 | BAUM MARK L CHIEF EXECUTIVE OFFICER · Director | Other | 79,994 | $3.76M⚡ | Form 4 |
| Apr 3, 2025 | BOLL ANDREW R. CFO | Option | 346,500 | — | Form 4 |
| Apr 7, 2025 | BOLL ANDREW R. CFO | Other | 136,745 | $3.16M⚡ | Form 4 |
| Apr 3, 2025 | SAHAREK JOHN P. CEO & President, ImprimisRx | Option | 277,200 | — | Form 4 |
| Apr 7, 2025 | SAHAREK JOHN P. CEO & President, ImprimisRx | Other | 109,475 | $2.53M⚡ | Form 4 |
| Apr 3, 2025 | BAUM MARK L CEO · Director | Option | 762,300 | — | Form 4 |
| Apr 7, 2025 | BAUM MARK L CEO · Director | Other | 300,363 | $6.94M⚡ | Form 4 |
| Nov 16, 2023 | BAUM MARK L CEO · Director | Purchase | 7,500 | $61K | Form 4 |
| Nov 10, 2023 | SAHAREK JOHN P. Chief Commercial Officer | Option | 20,000 | — | Form 4 |
| Nov 10, 2023 | SAHAREK JOHN P. Chief Commercial Officer | Other | 9,778 | $125K | Form 4 |
| Aug 14, 2023 | BAUM MARK L CEO · Director | Purchase | 5,800 | $99K | Form 4 |
| Aug 14, 2023 | Makary Martin A. Director | Purchase | 20,000 | $338K | Form 4 |
| Jul 18, 2023 | BAUM MARK L CEO · Director | Option | 762,300 | — | Form 4 |
| Jul 18, 2023 | BAUM MARK L CEO · Director | Other | 299,968 | $5.47M⚡ | Form 4 |
| Jul 18, 2023 | SAHAREK JOHN P. Chief Commercial Officer | Option | 277,200 | — | Form 4 |
| Jul 18, 2023 | SAHAREK JOHN P. Chief Commercial Officer | Other | 109,080 | $1.99M⚡ | Form 4 |
BAUM MARK L
CHIEF EXECUTIVE OFFICER · Director
日期
May 14
股数
10,000
均价
$30.20
总金额
$302K
BAUM MARK L
CHIEF EXECUTIVE OFFICER · Director
日期
Dec 12
股数
180,000
均价
$3.95
总金额
$711K
BAUM MARK L
CHIEF EXECUTIVE OFFICER · Director
日期
Dec 12
股数
79,994
均价
$47.06
总金额
$3.76M ⚡
SAHAREK JOHN P.
CEO & President, ImprimisRx
日期
Apr 7
股数
109,475
均价
$23.09
总金额
$2.53M ⚡
SAHAREK JOHN P.
Chief Commercial Officer
日期
Jul 18
股数
109,080
均价
$18.23
总金额
$1.99M ⚡
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 HROW 内幕交易
HROW 内幕交易
Harrow Health, Inc.（HROW）内幕交易数据来源于公司内部人（包括BAUM MARK L (CHIEF EXECUTIVE OFFICER · Director), BOLL ANDREW R. (PRESIDENT AND CFO), Graves Adrienne L (Director)）提交的SEC Form 4申报文件。过去12个月内，4位内部人向SEC提交了交易申报。HROW内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Harrow Health, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
HROW 内幕交易 · 5个问题Harrow Health, Inc.（HROW）的内部人包括高管和董事，如BAUM MARK L (CHIEF EXECUTIVE OFFICER · Director), BOLL ANDREW R. (PRESIDENT AND CFO), Graves Adrienne L (Director)等。过去12个月内，4位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026